Drug prices : Costly cures | The Economist
▻http://www.economist.com/news/business/21603453-american-fight-over-expensive-new-treatments-has-global-implicat
une bonne synthèse des problématiques de l’explosion du coût des #médicaments aux US
Sovaldi is a “tipping-point”, says Dr Miller. To date, most extremely expensive drugs have been for small groups of patients, such as those with a rare genetic disease. In contrast, about 3.2m Americans are estimated to have hepatitis C. If each was given Sovaldi at current prices, the cost would exceed $250 billion.